Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus

Clinical trial NCT00003326 · UNKNOWN

Trial details

NCT number: NCT00003326
Sponsor: Theradex
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 1997-09-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.